Thomson Reuters Identifies United Kingdom as a Leader in Dementia Research
(Thomson Reuters ONE) -
Amid high-caliber research output and citation impact, analysis reveals region
has unfilled potential to accelerate dementia cure
Philadelphia, PA, London, UK, March 20, 2012 - The Intellectual Property &
Science business of Thomson Reuters today announced findings that the quality of
dementia research in the United Kingdom (UK) is second in the world only to the
United States, despite the low number of scientists working in this field, and
that finding a cure can be accelerated by increasing the number of dementia
researchers and investment, according to work done using the Thomson Reuters Web
of Knowledge(TM). The findings are featured in an Alzheimer's UK Research Report
"Defeating Dementia."
The results from the analysis reveal the UK published more research on dementia
than any other country except the United States and ranks second in the world
after Sweden in citation impact, which is the number of times UK research is
referenced in dementia studies around the globe. Despite its high performance
and influence, dementia research capacity in the UK is low when compared to
cancer, stroke and heart disease. For every dementia research scientist there
are six who work on cancer.
"Research output and citation impact in scientific literature is an ideal way to
measure the quality and capacity of dementia research," said Karen Gurney,
manager of bibliometric reporting at Thomson Reuters and analyst of this report.
"This project illuminated an interesting dementia-research landscape in the UK,
where this region is clearly playing an influential role despite its size."
The research study was commissioned by the UK's leading dementia research
charity, Alzheimer's Research UK, in an effort to raise awareness and increase
investment for the underfunded field. The data measuring the quality and size of
dementia research in the UK was compiled by Thomson Reuters. Issued by
Alzheimer's UK, the report, Defeating Dementia, also outlines 14 recommendations
to the UK government based on feedback from scientists working in the field.
"The data provided by Thomson Reuters have been extremely valuable in allowing
Alzheimer's Research UK to uncover the facts about dementia research output and
quality in the UK," said Simon Ridley, head of research at Alzheimer's Research
UK. "We wanted to dig deep into the issue of UK research capacity in this field.
The work carried out by Thomson Reuters enabled us to do this and make a strong
case for more investment in dementia research."
Rebecca Wood, chief executive, Alzheimer's Research UK, concurs. "Alzheimer's
Research UK relies on robust data to support its expertise. The data provided by
Thomson Reuters allowed us to present an in-depth picture of UK dementia
research in a global context over the last fifty years. It has been very well-
received by a range of stakeholders, including government and other research
funders."
To view the Alzheimer's Research UK report, Defeating Dementia, visit:
www.alzheimersresearchuk.org.
Thomson Reuters
Thomson Reuters is the world's leading source of intelligent information for
businesses and professionals. We combine industry expertise with innovative
technology to deliver critical information to leading decision makers in the
financial, legal, tax and accounting, healthcare and science, and media markets,
powered by the world's most trusted news organization. With headquarters in New
York and major operations in London and Eagan, Minnesota, Thomson Reuters
employs more than 55,000 people and operates in over 100 countries. Thomson
Reuters shares are listed on the Toronto and New York Stock Exchanges. For more
information, go to www.thomsonreuters.com.
Alzheimer's Research UK
Alzheimer's Research UK is the UK's leading dementia research charity. As
research experts, we fund world-class, pioneering scientists at leading
universities to find preventions, treatments and a cure for dementia. Our
findings improve the lives of everyone affected by dementia now and in the
future. We forge partnerships with Government and other key organizations to
make dementia research a national priority.
CONTACT
Laura Gaze Jennifer Figueroa
Thomson Reuters, IP Solutions Thomson Reuters, IP Solutions
+1.203.868.3340 +1.972.342.9148
laura.gaze(at)thomsonreuters.com jennifer.figueroa(at)thomsonreuters.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Thomson Reuters Corporation via Thomson Reuters ONE
[HUG#1595590]
Unternehmensinformation / Kurzprofil:
Datum: 20.03.2012 - 10:01 Uhr
Sprache: Deutsch
News-ID 126362
Anzahl Zeichen: 5446
contact information:
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 203 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Thomson Reuters Identifies United Kingdom as a Leader in Dementia Research"
steht unter der journalistisch-redaktionellen Verantwortung von
Thomson Reuters Corporation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
